dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More Magazine Features

What will the right RIS system bring to your imaging department? There is no one-size-fits-all solution for RIS needs

PACS and opinions: What to consider when upgrading a PACS Experts weigh in on what to look for when entering the market

Current landscape and future trajectory for AI in healthcare Healthier patients and healthier bottom lines

Implants, gadolinium and AI: Changing perceptions in MR From hard questions over contrast retention to softening views on implants

Rad rooms get more complex while detectors lighten up A look around the industry at the latest radiology tools entering the market

See All Magazine Features  

Molecular Imaging Homepage

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Dennis Durmis MITA names chair of board of directors

Researchers find new PET tracer that better detects melanoma than 18F-FDG 18F-P3BZA could become the new gold standard

RadioMedix scores $2 million contract for Targeted Alpha-emitter therapy Treatment for neuroendocrine tumors

FDA clears United Imaging's total-body PET scanner Creating 3D images of entire human body in 15-30 seconds

FDA clears MIM SurePlan molecular radiotherapy software Can measure the absorbed dose from MRT for individual patients

Rob Beanlands ASNC names president for 2019

Former South African nuclear executives to appeal suspensions in court Involves monthslong shutdown of NTP Radioisotopes medical isotope plant

FDA grants Fast Track designation to 64-Cu-Dotatate Used in PET diagnostic exams for suspected neuroendocrine tumors

Editorial takes aim at NRC efforts to lower the bar for nuclear medicine providers 'The NRC has abdicated its role as a protection agency for patients' say authors

Are bundled payments hurting nuclear medicine access and innovation?

by Lauren Dubinsky , Senior Reporter
Bundled payments are intended to lower healthcare spending and achieve value-based care, but what happens when the reimbursement is a fraction of the cost to the provider?

This is a problem being faced concerning many radiopharmaceuticals today, and some experts believe that the consequences extend beyond patients receiving compromised care to actually damaging the adoption and development of better, emerging tracers.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Since different radiopharmaceuticals can cost anywhere between $20 and $3,000 per unit dose, bundling them into the same category means a facility will lose money performing an exam with expensive “supplies”.

For instance, if there is an average bundle package of $700 for a certain procedure and the radiopharmaceutical costs $1,200 then the hospital loses $500. And that doesn’t even factor in the cost of technology, salaries and radiologist reading fees.

Dr. Munir Ghesani
“In this model, they are not able to account for huge differences in the costs from one radiopharmaceutical to another,” said Dr. Munir Ghesani, associate professor of radiology at NYU Langone Medical Center, and a member of the government relations committee at the SNMMI. “As a result, a lot of physicians do not use the expensive radiopharmaceuticals.”

Although technically drugs, CMS classifies radiopharmaceuticals as supplies so it can incorporate them into bundled payments under Ambulatory Payment Classifications (APCs) in the Medicare Hospital Outpatient Prospective Payment System (OPPS).

“The reason for that is cost savings,” said Ghesani. “When you bundle things together, it usually saves money.”

And generally speaking, bundled payments are a great thing, he added, but he and his peers believe packaging radiopharmaceuticals with procedures may be doing more harm than good.

In addition to preventing Medicare patients from receiving the nuclear medicine procedures they require, the current reimbursement situation may also hinder innovation because companies don’t want to spend money on the development of a radiopharmaceutical that hospitals won’t purchase.

“That is a major concern and part of the reason why some of the major players in this field have backed out of developing radiopharmaceuticals,” said Ghesani.
  Pages: 1 - 2 - 3 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED